Hepatitis D Central

Healio spoke with Meg Doherty, MD, MPH, PhD, Director Global HIV, Hepatitis and STI Programmes at WHO, about elimination efforts for hepatitis D, including how hepatitis D would be affected by WHO Global Hepatitis Elimination goals and what U.S. physician can do to help work towards hepatitis elimination.

The COVID-19 pandemic has highlighted areas in which the medical community can improve patient care and access to treatment for numerous conditions, including hepatitis D virus.

Healio spoke with John D. Scott, MD, MSc, FIDSA, chief digital health officer at UW Medicine, professor of allergy and infectious diseases at University of Washington and medical director at the Liver Clinic at Harborview Medical Center, to learn more about what PCPs can do to help prevent and screen for HDV.

July 28 is World Hepatitis Day, and this year’s theme, “I can’t wait,” emphasizes the importance of testing and treatment and the need for greater global response to viral hepatitis elimination efforts.

LONDON — Bulevirtide induced a greater combined virologic and biochemical response compared with control at 48 weeks in patients with chronic hepatitis D infection, according to research.

May 19 is Hepatitis Testing Day, and in this Healio video exclusive, Nancy S. Reau, MD, FAASLD, AGAF, stresses the importance of screening and vaccination to reach global hepatitis elimination.

May is Hepatitis Awareness Month, and the CDC and its public health partners are raising awareness and encouraging increased screening and vaccination.

Bulevirtide improved quality of life measures among patients treated for chronic hepatitis D virus, Maria Buti, MD, PhD, of the Hospital Universiario Valle Hebron, told Healio Gastroenterology.

Without approved treatment options for hepatitis D, screening has largely fallen by the wayside; however, promising therapies in phase 3 trials may shift that paradigm, according to a presenter at the GUILD Conference.

Direct-acting antivirals for hepatitis C have dominated hepatitis research for the past decade and have revolutionized the treatment of HCV, but the emergence of new treatment options has put hepatitis D back in the spotlight.